Jharkhand Chief Minister Hemant Soren has sought permission from the Indian central government to import 50,000 vials of Remdesivir from Bangladeshi pharmaceutical companies for emergency use. He has written to D.V. Sadananda Gowda, Indian Cabinet Minister, Ministry of Chemicals and Fertilizers, requesting him to allow import and use of the medicine. Read Nigeria collects coronavirus medicine from Bangladesh “With the increasing demand for Remedisivir for critical patients in Jharkhand & its unavailability, we have reached out to Pharma companies in Bangladesh for buying around 50,000 vials for emergency use. I have written to DV Sadanand Gowda for permission to import as soon as possible,” Chief Minister Soren tweeted. He said they have been able to get a quotation from Beximco Pharmaceuticals Ltd for 50,000 vials of Demsivir Injection (Remdesivir) at a total cost of US$ 1 million, which the Jharkhand government is willing to procure at the earliest in light of the pressing needs of this medicine. Also read: Covid-19 turns India into vaccine importer from exporter “I would request you to kindly allow us to import and use the above mentioned medicine from the said company of Bangladesh so that we are able to save the precious lives,” Soren wrote in his letter to Minister Gowda. Currently Eskayef (SK-F), Beacon, Incepta, Beximco, Healthcare and Square are producing the drug, which was first developed by US biopharmaceutical company Gilead Sciences. Also read: Beximco Pharmaceuticals hands over 1000 doses of Remdesivir to Health Ministry Remdesivir was the first drug approved by US regulator the Food and Drug Administration (FDA) for treating the SARS-CoV-2 virus. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older.  Full approval was preceded by the US FDA issuing an EUA (emergency use authorization) on May 1, 2020 to allow prescribing remdesivir for severe COVID-19 (confirmed or suspected) in hospitalized adults and children, according to Medscape. Read Beximco Pharmaceuticals hands over 1000 doses of Remdesivir to Health Ministry

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.

A person familiar with President Donald Trump’s medical condition has said the president had been administered supplemental oxygen at the White House on Friday before he was hospitalized.

Foreign Minister Dr AK Abdul Momen has called for more investments from Spain as well as sharing expertise, especially in energy and tourism sector with Bangladesh.

Fresh studies  by British researchers give more information about what medicines do or don’t work  in COVID-19 treatment.

Nigeria on Sunday has procured two types of coronavirus medicine – Remdesivir and Remivir – from Bangladesh on an emergency chartered flight.

Bangladesh High Commissioner to the UK Saida Muna Tasneem has called upon the United Kingdom to be the voice and conscience of the most vulnerable countries including the LDCs, SIDs and countries with special needs, and ensure equitable and affordable access to vaccines and therapeutics manufactured by the UK and other developed countries. 

The Health Ministry on Thursday received one thousand doses of a generic version of Remdesivir - the intravenous drug that has been shown in one trial to reduce the time needed for recovery from Covid-19 - from Beximco Pharmaceuticals, for treatment of serious Covid-19 patient.